Literature DB >> 10858235

The putative proteinase maturation protein A of Streptococcus pneumoniae is a conserved surface protein with potential to elicit protective immune responses.

K Overweg1, A Kerr, M Sluijter, M H Jackson, T J Mitchell, A P de Jong, R de Groot, P W Hermans.   

Abstract

Surface-exposed proteins often play an important role in the interaction between pathogenic bacteria and their host. We isolated a pool of hydrophobic, surface-associated proteins of Streptococcus pneumoniae. The opsonophagocytic activity of hyperimmune serum raised against this protein fraction was high and species specific. Moreover, the opsonophagocytic activity was independent of the capsular type and chromosomal genotype of the pneumococcus. Since the opsonophagocytic activity is presumed to correlate with in vivo protection, these data indicate that the protein fraction has the potential to elicit species-specific immune protection with cross-protection against various pneumococcal strains. Individual proteins in the extract were purified by two-dimensional gel electrophoresis. Antibodies raised against three distinct proteins contributed to the opsonophagocytic activity of the serum. The proteins were identified by mass spectrometry and N-terminal amino acid sequencing. Two proteins were the previously characterized pneumococcal surface protein A and oligopeptide-binding lipoprotein AmiA. The third protein was the recently identified putative proteinase maturation protein A (PpmA), which showed homology to members of the family of peptidyl-prolyl cis/trans isomerases. Immunoelectron microscopy demonstrated that PpmA was associated with the pneumococcal surface. In addition, PpmA was shown to elicit species-specific opsonophagocytic antibodies that were cross-reactive with various pneumococcal strains. This antibody cross-reactivity was in line with the limited sequence variation of ppmA. The importance of PpmA in pneumococcal pathogenesis was demonstrated in a mouse pneumonia model. Pneumococcal ppmA-deficient mutants showed reduced virulence. The properties of PpmA reported here indicate its potential for inclusion in multicomponent protein vaccines.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10858235      PMCID: PMC101721          DOI: 10.1128/IAI.68.7.4180-4188.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  54 in total

1.  Host cellular immune response to pneumococcal lung infection in mice.

Authors:  A Kadioglu; N A Gingles; K Grattan; A Kerr; T J Mitchell; P W Andrew
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Association of intrastrain phase variation in quantity of capsular polysaccharide and teichoic acid with the virulence of Streptococcus pneumoniae.

Authors:  J O Kim; J N Weiser
Journal:  J Infect Dis       Date:  1998-02       Impact factor: 5.226

3.  Error-tolerant identification of peptides in sequence databases by peptide sequence tags.

Authors:  M Mann; M Wilm
Journal:  Anal Chem       Date:  1994-12-15       Impact factor: 6.986

4.  A new family of peptidyl-prolyl isomerases.

Authors:  K E Rudd; H J Sofia; E V Koonin; G Plunkett; S Lazar; P E Rouviere
Journal:  Trends Biochem Sci       Date:  1995-01       Impact factor: 13.807

5.  Destruction of low efficiency markers is a slow process occurring at a heteroduplex stage of transformation.

Authors:  N B Shoemaker; W R Guild
Journal:  Mol Gen Genet       Date:  1974

6.  Identification of pneumococcal surface protein A as a lactoferrin-binding protein of Streptococcus pneumoniae.

Authors:  S Hammerschmidt; G Bethe; P H Remane; G S Chhatwal
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

7.  Multidrug-resistant Streptococcus pneumoniae in Poland: identification of emerging clones.

Authors:  K Overweg; P W Hermans; K Trzcinski; M Sluijter; R de Groot; W Hryniewicz
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

8.  Intranasal immunization of mice with PspA (pneumococcal surface protein A) can prevent intranasal carriage, pulmonary infection, and sepsis with Streptococcus pneumoniae.

Authors:  H Y Wu; M H Nahm; Y Guo; M W Russell; D E Briles
Journal:  J Infect Dis       Date:  1997-04       Impact factor: 5.226

9.  Truncated Streptococcus pneumoniae PspA molecules elicit cross-protective immunity against pneumococcal challenge in mice.

Authors:  R C Tart; L S McDaniel; B A Ralph; D E Briles
Journal:  J Infect Dis       Date:  1996-02       Impact factor: 5.226

10.  Relationship between cell surface carbohydrates and intrastrain variation on opsonophagocytosis of Streptococcus pneumoniae.

Authors:  J O Kim; S Romero-Steiner; U B Sørensen; J Blom; M Carvalho; S Barnard; G Carlone; J N Weiser
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

View more
  23 in total

1.  A typhus group-specific protease defies reductive evolution in rickettsiae.

Authors:  Nicole C Ammerman; Joseph J Gillespie; Andrew F Neuwald; Bruno W Sobral; Abdu F Azad
Journal:  J Bacteriol       Date:  2009-10-09       Impact factor: 3.490

2.  Mutation of the maturase lipoprotein attenuates the virulence of Streptococcus equi to a greater extent than does loss of general lipoprotein lipidation.

Authors:  Andrea Hamilton; Carl Robinson; Iain C Sutcliffe; Josh Slater; Duncan J Maskell; Nick Davis-Poynter; Ken Smith; Andrew Waller; Dean J Harrington
Journal:  Infect Immun       Date:  2006-10-02       Impact factor: 3.441

3.  Surface lipoprotein PpiA of Streptococcus mutans suppresses scavenger receptor MARCO-dependent phagocytosis by macrophages.

Authors:  Tadashi Mukouhara; Takafumi Arimoto; Kasei Cho; Matsuo Yamamoto; Takeshi Igarashi
Journal:  Infect Immun       Date:  2011-10-10       Impact factor: 3.441

Review 4.  Microbial peptidyl-prolyl cis/trans isomerases (PPIases): virulence factors and potential alternative drug targets.

Authors:  Can M Ünal; Michael Steinert
Journal:  Microbiol Mol Biol Rev       Date:  2014-09       Impact factor: 11.056

5.  Analysis of the transcriptome of group A Streptococcus in mouse soft tissue infection.

Authors:  Morag R Graham; Kimmo Virtaneva; Stephen F Porcella; Donald J Gardner; R Daniel Long; Diane M Welty; William T Barry; Claire A Johnson; Larye D Parkins; Fred A Wright; James M Musser
Journal:  Am J Pathol       Date:  2006-09       Impact factor: 4.307

6.  Antibodies to the iron uptake ABC transporter lipoproteins PiaA and PiuA promote opsonophagocytosis of Streptococcus pneumoniae.

Authors:  Maha Jomaa; Jose Yuste; James C Paton; Christopher Jones; Gordon Dougan; Jeremy S Brown
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

7.  Identification of the targets of cross-reactive antibodies induced by Streptococcus pneumoniae colonization.

Authors:  Aoife M Roche; Jeffrey N Weiser
Journal:  Infect Immun       Date:  2010-03-15       Impact factor: 3.441

8.  Serum immunoglobulin G response to candidate vaccine antigens during experimental human pneumococcal colonization.

Authors:  Tera L McCool; Thomas R Cate; Elaine I Tuomanen; Peter Adrian; Tim J Mitchell; Jeffrey N Weiser
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

9.  Contribution of lipoproteins and lipoprotein processing to endocarditis virulence in Streptococcus sanguinis.

Authors:  Sankar Das; Taisei Kanamoto; Xiuchun Ge; Ping Xu; Takeshi Unoki; Cindy L Munro; Todd Kitten
Journal:  J Bacteriol       Date:  2009-04-24       Impact factor: 3.490

Review 10.  Pneumococcal vaccination and revaccination of older adults.

Authors:  Andrew S Artz; William B Ershler; Dan L Longo
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.